Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06341829

Visuospatial and Affective Abilities in Parkinson Disease

Assessment and Rehabilitation of Visuospatial and Affective Abilities in Parkinson Disease

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
IRCCS Centro Neurolesi Bonino Pulejo · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to investigate whether prismatic adaptation (PA) and virtual prismatic adaptation (VPA), a non-invasive neuromodulation technique, that involves the use of lenses that deviate the visual field, can modulate alexithyima and performance in visuospatial tasks in patients with Parkinson disease. Furthermore, brain activity during the prismatic adaptation and post-adaptation phases will be recorded using functional near-infrared spectroscopy (fNIRS) and high-density electroencephalography (HD-EEG). Based on these premises, the present project aims to investigate the deficits of the affective, motor and visuospatial abilities in Parkinson's patients and the modulation of disorders through prismatic adaptation (PA) and virtual prism adaptation (VPA). Finally, we would like to evaluate production of the tear film and correlate their quantity with the severity of PD as it could be proposed as a new, non-invasive biomarker.

Conditions

Interventions

TypeNameDescription
OTHERPrismatic adaptationParticipants will fit with prismatic goggles that deviate their visual field by 13° either leftward or rightward. They will seat in front of a white horizontal board on which three target dots (5 mm diameter) were positioned at 0, -10 and +10° from their body midline at a distance of 57 cm from their eyes. They will perform a total of 150 verbally instructed pointing movements with their right index finger towards the right (+10°) and left (-10°) targets in a pseudorandom order.
DIAGNOSTIC_TESTSchirmer testTear film will be collected from the right and left eyes.

Timeline

Start date
2024-04-30
Primary completion
2024-05-01
Completion
2026-02-28
First posted
2024-04-02
Last updated
2026-02-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06341829. Inclusion in this directory is not an endorsement.